Tongfang Kontafarma Holdings Limited provided consolidated earnings guidance for the six months ended 30 June 2022. The Group is expected to record a consolidated net loss for the six months ended 30 June 2022 of approximately HKD 28.4 million to HKD 42.7 million as compared to the consolidated net loss of approximately HKD 73.2 million for the corresponding period in 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.032 HKD | 0.00% | 0.00% | -11.11% |
May. 02 | Active Gains Files Winding-Up Petition Against Kontafarma China's Subsidiary | MT |
Apr. 19 | Kontafarma China Holdings Limited Announces Management Changes, Effect from 19 April 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.11% | 22.89M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 1312 Stock
- News Kontafarma China Holdings Limited
- Tongfang Kontafarma Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022